Immunomedics (IMMU) Misses Q1 EPS by 2c
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Immunomedics (IMMU) click here.